Moderna, Inc. Price Today
Moderna, Inc.
MRNA
Healthcare
$27.37B
💰
Market Cap
25.0
💸
Price to Earnings
$2.9
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
12 |
Strong Buy |
4 |
Hold |
10 |
Sell |
2 |
Strong Sell |
0 |
MRNA Price Forecast Target
71.9 👉 405.5 +464%
MRNA EPS Forecast
2.9 👉 -5.1 +-278%
Financials
Profit Margin
11 %
Revenue Growth
-92.8 %
Dividend
$ 0
Held Percent
9.7% - Insiders
69.5% - Institutions
20.8% - Public
Major Fund Holders
-
💰 Baillie Gifford and Company $5.6B
-
💰 Vanguard Group Inc $3.3B
-
💰 Blackrock Inc. $2.9B
-
💰 State Street Corporation $1.7B
-
💰 Flagship Pioneering Inc. $1.6B
Stock Ideas
Elon Musk Portfolio
Enter the visionary world of Elon Musk, a name that needs no introduction in the realms of innovation, entrepreneurship, and technology. With a trailblazing spirit and an unyielding drive, Musk has become a household name, propelling himself to extr…
Seth Klarman Portfolio
Seth Klarman's investment prowess is exemplified by his exceptional track record. Since the inception of his fund until 2008, he achieved an impressive compound return-on-investment of 20%. This remarkable achievement showcases his astute investment…
Ray Dalio Portfolio
Ray Dalio, a visionary entrepreneur and investment strategist, laid the foundation of Bridgewater with a clear vision in mind. His relentless pursuit of excellence, coupled with an unwavering commitment to innovation, has propelled Bridgewater to be…
Bruce Berkowitz Portfolio
Bruce Berkowitz, the esteemed founder of Fairholme, has established himself as a prominent figure in the investment world with his exceptional portfolio strategy. Since its inception in 1999, Fairholme has grown into a formidable $19 billion mutual …📮FAQ
Some Frequently Asked Questions.
The Moderna, Inc. industry is Biotechnology
The Moderna, Inc. sector is Healthcare
The Moderna, Inc. forecasted predicted Price to Earnings PE ratio is -14.0
The Moderna, Inc. Price to Earnings PE ratio is 25.0
The Market Capitalization of Moderna, Inc. is $27.37B
There are total of 343446751 float shares with 69.5% held by Institutions and 9.7% held by insiders
The MModerna, Inc. forecasted Earnings per Share EPS is $-5.1
The Moderna, Inc. Earnings per Share EPS is 2.9
The Moderna, Inc. company has $10552000000 gross profits with 11 profit margins
The Moderna, Inc. Earnings Growth is 0% with 0% quarterly earnings growth
The Moderna, Inc. Revenue is $10654000128 with -0.928 revenue growth
The price target for Moderna, Inc. stock is $405.5 for the high target and $60.4 for the low target
The consensus analyst recommendations for Moderna, Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Moderna, Inc. is Buy, with the following breakdown:
- Buy: 12
- Strong Buy: 4
- Hold: 10
- Sell: 2
- Strong Sell: 0
The Beta of Moderna, Inc. is 1.6
The dividend of Moderna, Inc. is $0
The dividend yield of Moderna, Inc. is 0%
The biggest institutional and mutual fund holders of Moderna, Inc. stock are
- Baillie Gifford and Company
- Vanguard Group Inc
- Blackrock Inc.
- State Street Corporation
The Moderna, Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0